{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:37:34Z","timestamp":1794631054016,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Datta Meghe Institute of Higher Education and Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Oral squamous cell carcinoma <jats:bold>(<\/jats:bold>OSCC) associated with oral submucous fibrosis (OSMF) constitutes a clinicopathologically distinct entity in context to younger age of presentation, better histological grade of tumor differentiation, and lower risk of nodal metastasis. This study is intended to provide the basis of clinical presentation of OSCC associated with OSMF to consider a clinicopathologically unique entity compared to OSCC without OSMF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The cohort of 320 OSCC patients was divided into two groups based on the association of OSMF. Group one, OSCC without OSMF (<jats:italic>n<\/jats:italic>\u2009=\u2009166), whereas Group two, OSCC associated with OSMF (<jats:italic>n<\/jats:italic>\u2009=\u2009154). The varied clinical presentation were categorized as, erythroplakic, erythro-leukoplakic, ulcerative\/endophytic, ulcero-proliferative, and proliferative\/exophytic. The variations in clinical presentation between the OSCC without OSMF and OSCC associated with OSMF groups were assessed using one-way ANOVA and the Tukey\u2019s HSD test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Group one cohort presented with, significantly high number of cases clinically as ulcerative\/endophytic 72 (43.4%) followed by ulcero-proliferative 53 (31.9%), erythro-leukoplakic 30 (18.1%), proliferative\/exophytic 8 (4.8%) and erythroplakic 3 (1.8%). Whereas in Group two, significantly high number of cases clinically presented as nearly equal number of ulcero-proliferative 55 (35.7%) and proliferative\/exophytic 50 (32.5%) followed by ulcerative\/endophytic 25 (16.2%), erythro-leukoplakic 18 (11.7%) and erythroplakic 6 (3.9%) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Significantly high number of cases of OSCC associated with OSMF clinically presented as ulcero-proliferative and proliferative\/exophytic. This characteristic clinical presentation may contribute in early detection and diagnosis by providing considerable period for recognition and treatment planning and thus better prognosis in OSCC associated with OSMF cases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14415-2","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T02:54:10Z","timestamp":1749092050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Correlation of clinical presentation with prognosis in oral squamous cell carcinoma associated with oral submucous fibrosis"],"prefix":"10.1186","volume":"25","author":[{"given":"H. Hande","family":"Alka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gadbail","family":"Amol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonone","family":"Archana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Patil","family":"Swati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakhale","family":"Aayushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Sharma","family":"Preethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"14415_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/jomfp.JOMFP_275_17","volume":"23","author":"S Acharya","year":"2019","unstructured":"Acharya S, Rahman S, Hallikeri K. A retrospective study of clinicopathological features of oral squamous cell carcinoma with and without oral submucous fibrosis. J Oral Maxillofac Pathol. 2019;23:162.","journal-title":"J Oral Maxillofac Pathol"},{"key":"14415_CR2","unstructured":"World Health Organization International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, Volume 85. Betel-Quid and Areca-Nut Chewing and Some Areca Nut Derived Nitrosamines. Lyon, France: IARC Press, 2004."},{"key":"14415_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.oraloncology.2005.08.005","volume":"42","author":"WM Tilakaratne","year":"2006","unstructured":"Tilakaratne WM, Klinikowski MF, Takashi S, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on etiology and pathogenesis. Oral Oncol. 2006;42:561\u20138.","journal-title":"Oral Oncol"},{"key":"14415_CR4","first-page":"113","volume":"11","author":"PC Gupta","year":"1998","unstructured":"Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC. Oral submucous fibrosis in india: a new epidemic? Natl Med J India. 1998;11:113\u20136.","journal-title":"Natl Med J India"},{"key":"14415_CR5","first-page":"263","volume":"2","author":"I Chiba","year":"2001","unstructured":"Chiba I. Prevention of BQ chewers\u2019 oral cancer in the Asian-Pacific area. Asian Pac J Cancer Prev. 2001;2:263\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"14415_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s12663-015-0760-y","volume":"14","author":"NR Chourasia","year":"2015","unstructured":"Chourasia NR, Borle RM, Vastani A. Concomitant association of oral submucous fibrosis and oral squamous cell carcinoma and incidence of malignant transformation of oral submucous fibrosis in a population of central india: a retrospective study. J Maxillofac Oral Surg. 2015;14:902\u20136.","journal-title":"J Maxillofac Oral Surg"},{"key":"14415_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.mehy.2013.07.001","volume":"81","author":"SC Sarode","year":"2013","unstructured":"Sarode SC, Sarode GS. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis. Med Hypotheses. 2013;81:540\u20133.","journal-title":"Med Hypotheses"},{"key":"14415_CR8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hed.23143","volume":"35","author":"P Chaturvedi","year":"2012","unstructured":"Chaturvedi P, Vaishampayan SS, Nair S, et al. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease. Head Neck. 2012;35:1404\u20139.","journal-title":"Head Neck"},{"issue":"6","key":"14415_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/jop.12553","volume":"46","author":"AR Gadbail","year":"2017","unstructured":"Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade SA, Korde S, Zade P, Bhowate R, Borle R, et al. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med. 2017;46(6):448\u201353.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"14415_CR10","first-page":"575","volume":"3","author":"M Bouckaert","year":"2016","unstructured":"Bouckaert M, Munzhelele TI, Feller L, Lemmer J, Khammissa RAG. The clinical characteristics of oral squamous cell carcinoma in patients attending the Medunsa oral health centre, South Africa. Integr Cancer Sci Th. 2016;3(5):575\u201378.","journal-title":"Integr Cancer Sci Th"},{"key":"14415_CR11","doi-asserted-by":"crossref","unstructured":"Siriwardena BSMS, Jayawardena KLTD, Senarath NH, Tilakaratne WM. An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma. Biomed Res Int. 2018; 2018:4154165.","DOI":"10.1155\/2018\/4154165"},{"key":"14415_CR12","volume-title":"Manual for staging of cancer","author":"American Joint Committee on Cancer","year":"2002","unstructured":"American Joint Committee on Cancer. Manual for staging of cancer. Heidelberg: Springer; 2002."},{"issue":"7","key":"14415_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/jcm11071793","volume":"11","author":"V Murthy","year":"2022","unstructured":"Murthy V, Mylonas P, Carey B, Yogarajah S, Farnell D, Addison O, et al. Malignant transformation rate of oral submucous fibrosis: A systematic review and Meta-Analysis. J Clin Med. 2022;11(7):1793.","journal-title":"J Clin Med"},{"issue":"3","key":"14415_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.oooo.2017.04.014","volume":"124","author":"P Chaturvedi","year":"2017","unstructured":"Chaturvedi P, Malik A, Nair D, Nair S, Mishra A, Garg A, Vaishampayan S. Oral squamous cell carcinoma associated with oral submucous fibrosis have better oncologic outcome than those without. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124(3):225\u201330.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"14415_CR15","doi-asserted-by":"crossref","unstructured":"Jayasinghe LA, Peiris PM, Tilakaratne WM, Attygalla AM, Jayasinghe RD, Sitheeque MA et al. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases.oral Surg oral med oral pathol oral radiol. 2016; 122:210\u201315.","DOI":"10.1016\/j.oooo.2016.06.001"},{"issue":"5","key":"14415_CR16","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1590\/1679-775720130317","volume":"21","author":"FR Pires","year":"2013","unstructured":"Pires FR, Ramos AB, Oliveira JB, Tavares AS, Luz PS, Santos TC. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J Appl Oral Sci. 2013;21(5):460\u20137.","journal-title":"J Appl Oral Sci"},{"issue":"1","key":"14415_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40463-020-0399-7","volume":"49","author":"NR Rao","year":"2020","unstructured":"Rao NR, Villa A, More CB, Jayasinghe RD, Kerr AR, Johnson NW. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg. 2020;49(1):3.","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"9","key":"14415_CR18","first-page":"4491","volume":"17","author":"RB Zain","year":"2016","unstructured":"Zain RB, Kallarakkal TG, Ramanathan A, Kim J, Tilakaratne WM, Takata T, Warnakulasuriya S, Hazarey VK, Rich A, Hussaini HM, Jalil A. Exophytic verrucous hyperplasia of the oral Cavity\u2013 Application of standardized criteria for diagnosis from a consensus report. Asian Pac J Cancer Prev. 2016;17(9):4491.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"14415_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4103\/jomfp.JOMFP_276_19","volume":"23","author":"AM Shah","year":"2019","unstructured":"Shah AM, Bansal S, Shirsat PM, Prasad P, Desai RS. Exophytic verrucous hyperplasia in oral submucous fibrosis: A single-center study. J Oral Maxillofac Pathol. 2019;23(3):393\u201399.","journal-title":"J Oral Maxillofac Pathol"},{"key":"14415_CR20","doi-asserted-by":"crossref","unstructured":"Bolesina N, Femopase FL, Silvia A, Blanc L, Morelatto RA, Olmos MA. Oral squamous cell carcinoma clinical aspects, oral cancer. In Tech. 2012. Available from: http:\/\/www.intechopen.com\/books\/oralcancer\/oral-squamous cell- carcinoma-clinical-aspects","DOI":"10.5772\/32968"},{"issue":"8","key":"14415_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1600-0714.2009.00790.x","volume":"38","author":"YP Wang","year":"2009","unstructured":"Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, Kuo YS, Chiang CP. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications. J Oral Pathol Med. 2009;38(8):651\u20136.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"14415_CR22","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.3390\/ijms24054992","volume":"24","author":"X Qin","year":"2023","unstructured":"Qin X, Ning Y, Zhou L, Zhu Y. Oral submucous fibrosis: etiological mechanism, malignant transformation, therapeutic approaches and targets. Int J Mol Sci. 2023;24(5):4992.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14415-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14415-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14415-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:51:35Z","timestamp":1757181095000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14415-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14415"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14415-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Ethics Committee of Datta Meghe Institute of Medical Sciences (Deemed to be University) now renamed as Datta Meghe Institute of Higher Education and Research (Deemed to be University) as granted its approval to the required procedure for this investigation, which involved a retrospective analysis \u201c(DMIMS (DU) IEC\/Dec-2019\/8556- dated-17-12-2019)\u201d. All experiments were performed in accordance with relevant guidelines and regulations. The study was carried out in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written informed consent was acquired from the patients regarding use of their data and archival tissue samples.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1000"}}